Transmission Dynamics of Carbapenemase Genes in Carbapenem-Resistant Enterobacter cloacae: Evidence from Guangdong Hospitals

Study Background and Research Question

Carbapenem-resistant Enterobacteriaceae (CRE) are a major global health threat, with Enterobacter cloacae (CREC) ranking among the most prevalent multidrug-resistant pathogens in China. The COVID-19 pandemic has exacerbated the problem by increasing antibiotic usage and disrupting infection control, potentially accelerating the spread of resistance. Despite these concerns, detailed molecular epidemiological studies of carbapenemase-encoding genes (CEGs) in CREC, particularly their transmission dynamics, have been lacking. The reference study (Chen et al., 2025) addresses this gap by examining the prevalence, genetic context, and mobility of CEGs in CREC isolates from eight teaching hospitals in Guangdong Province between 2022 and 2024.

Key Innovation from the Reference Study

The central innovation lies in the integration of molecular typing, plasmid analysis, and epidemiological data to map the transmission of CEGs—especially the blaNDM−1 gene—within clinical settings. By distinguishing chromosomal from plasmid-borne carbapenemase genes and quantifying their horizontal transfer rates, the study advances our understanding of how resistance spreads in hospital environments. This approach enables more precise identification of the genetic vectors driving multidrug resistance in CREC populations.

Methods and Experimental Design Insights

The study analyzed 54 non-duplicate CREC isolates collected over 18 months. Key methodological elements include:

• Plasmid profiling and elimination: Variable temperature Sodium Dodecyl Sulfate (SDS) treatment was used to cure plasmids, followed by PCR screening to localize CEGs on chromosomes versus plasmids.
• Gene detection: PCR assays targeted key carbapenemase genes (blaNDM−1, blaIMP, blaKPC−2) and assessed their distribution.
• Antibiotic susceptibility: Broth microdilution determined resistance profiles, including to gentamicin—a representative aminoglycoside antibiotic.
• Plasmid conjugation: Mating experiments quantified the transferability of CEGs between strains.
• Molecular epidemiology: ERIC-PCR and NTSYS software generated genotypic clusters, revealing clonal relationships among isolates.
• Mobile genetic element analysis: PCR detection of insertion sequences and transposons clarified the genetic context of CEG mobility.

These methods provide a comprehensive view of both the genetic and phenotypic mechanisms underlying CREC resistance during a period of heightened clinical risk.

Core Findings and Why They Matter

• High CEG prevalence: 85.19% of CREC isolates harbored carbapenemase genes (Chen et al., 2025), with blaNDM−1 being the most common, found on plasmids, chromosomes, or both.
• Predominance of plasmid-borne blaNDM−1: 46.30% of isolates carried blaNDM−1 exclusively on plasmids, while 33.33% had it on both chromosomes and plasmids. This highlights plasmids as key vehicles for resistance dissemination.
• Efficient horizontal transfer: Conjugation experiments demonstrated a 95.65% success rate for CEG transfer, indicating robust potential for inter-strain spread within hospitals.
• Multidrug resistance: CEG-positive strains showed significantly higher resistance rates to multiple antibiotics, including gentamicin, compared to CEG-negative strains, underscoring the clinical challenge posed by these isolates.
• Diverse genetic backgrounds: Seventeen genotypes were identified, with type E and G most prevalent, found across different departments and hospitals, indicating both clonal expansion and horizontal gene transfer.
• Mobile genetic elements: Six types were found, with ISEcp1 present in 87.04% of isolates and many strains harboring multiple elements, further promoting gene mobility.
• Epidemiological trends: The highest CEG detection rates were in male patients, the elderly, respiratory medicine departments, and sputum samples. These patient and sample types represent critical surveillance targets.

These findings collectively point to the urgent need for enhanced infection control and molecular monitoring to limit the spread of highly mobile resistance determinants in hospital environments.

Comparison with Existing Internal Articles

The reference study's focus on the genetic epidemiology and transferability of CEGs in CREC complements prior literature on aminoglycoside antibiotics and resistance mechanisms. Articles such as "Gentamycin Sulfate in Bacterial Ribosome Fidelity and Resistance Research" and "Gentamycin Sulfate: Mechanistic Leverage for Translational Resistance Research" explore how aminoglycoside antibiotics like Gentamycin Sulfate provide experimental leverage for dissecting ribosomal function and resistance emergence in Gram-negative bacteria. While these articles address molecular mechanisms and assay design, the reference paper adds a real-world, epidemiological layer—linking genotype to phenotype and tracking resistance gene movement across hospitals. This connection is critical for translating molecular insights into effective surveillance and intervention strategies. Similarly, "Gentamycin Sulfate: Precision in Bacterial Protein Synthesis Research" provides workflow recommendations for using Gentamycin Sulfate in ribosome function analysis, which are directly relevant for studies modeling aminoglycoside susceptibility and resistance in CREC.

Limitations and Transferability

Several limitations must be considered. The study is geographically confined to eight hospitals in Guangdong, potentially limiting broader applicability. The relatively small sample size (n=54) may not capture the full genetic diversity of CREC. Furthermore, the focus on selected carbapenemase genes (blaNDM−1, blaIMP, blaKPC−2) may overlook other resistance determinants. Finally, the observational design precludes direct inference of clinical outcomes from molecular findings. Nevertheless, the robust molecular and epidemiological methodologies employed make the findings highly transferable to similar hospital settings, particularly where Gram-negative bacterial infection modeling and transmission studies are prioritized.

Protocol Parameters

• Antibiotic susceptibility testing: Use broth microdilution to determine MICs for key antibiotics, including gentamicin, ceftazidime/avibactam, and carbapenems, following CLSI or EUCAST guidelines.
• Plasmid curing: Apply variable temperature SDS treatment to eliminate plasmids prior to PCR screening for chromosomal versus plasmid localization of resistance genes.
• Conjugation assays: Perform filter mating or liquid mating protocols to evaluate the transferability of resistance plasmids, monitoring for recipient growth on selective media.
• Molecular typing: Employ ERIC-PCR and cluster analysis software (e.g., NTSYS) to assess genotypic relationships among isolates in transmission studies.
• Mobile genetic element screening: Use targeted PCR to detect insertion sequences (e.g., ISEcp1) and characterize genetic contexts of CEGs.

These protocols are informed by the reference study and established bacterial protein synthesis research workflows.

Research Support Resources

Researchers modeling bacterial protein synthesis inhibition, ribosome function, or the study of antibiotic resistance mechanisms in Gram-negative systems can leverage Gentamycin Sulfate as a validated aminoglycoside antibiotic. For detailed reagent information and handling guidelines, Gentamycin Sulfate (SKU A2514) is available from APExBIO and is widely used in both MIC determination and mechanistic resistance studies. Its specificity for the bacterial 30S ribosomal subunit makes it a valuable tool for experimental systems mirroring those described in the Guangdong CREC transmission study. Always consult product documentation for recommended storage, solubility, and purity specifications to ensure experimental consistency.